Načítá se...
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML
The design of selective small-molecules is often stymied by similar ligand binding pockets. Here, we report BSJ-03–123, a phthalimide-based degrader that exploits protein-interface determinants to achieve proteome-wide selectivity for the degradation of cyclin-dependent kinase 6 (CDK6). Pharmacologi...
Uloženo v:
| Vydáno v: | Cell Chem Biol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6444916/ https://ncbi.nlm.nih.gov/pubmed/30595531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2018.11.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|